News | Implantable Cardiac Monitor (ICM) | March 14, 2017

Heart Monitoring Technology Reveals Risks for Climbers at High Altitudes

Findings reveal 50 percent of the subjects experienced significant pauses in their heartbeat over the course of 51 days

heart monitoring technology, climbers, high altitudes, Circulation study, cardiac diagnostics, Medtronic, Reveal LINQ

March 14, 2017 — Climbing above 4,000 meters can provoke abnormal heart rhythms in otherwise healthy mountaineers, with the abnormalities increasing with altitude, new research has shown.

The study, by sports scientists at Leeds Beckett University (U.K.) and cardiologists at Poole Hospital, found that in a team of 16 healthy mountaineers without a previous history of heart disease, more than half (56.3 percent) experienced rhythm disturbances at altitudes of 4,100 meters or above.

These were either significant pauses in their heartbeat — where the heart stops for three seconds or more — or very fast or irregular heartbeats. The pauses generally took place at night, while the climbers were asleep. All identified abnormalities disappeared once climbers descended below 4,100 meters.

The research, published in the journal Circulation, was carried out with a team of military volunteers from the Defence Medical Services during an expedition to climb Nepal’s Mount Dhaulagiri, in the Himalayas.

The research is the first to continually monitor climbers’ heartbeat over an extended period and shows the potential for such technologies to help with medical diagnoses in remote locations.

The group was studied over a period of at least four months, both before, during and after the 51-day expedition, using implantable cardiac monitors, called Reveal LINQ. Similar in size to a AAA battery the devices were developed by Medtronic. They are typically used in clinical care to detect rare cardiac events but had not previously been tried at high altitude.

Heart rate and activity data were continuously recorded by the device and could be uploaded to a remote stored server by a cellular signal or manually for analysis. The climbers could also trigger the device to specifically store extended recordings of their heartbeat if they experienced any concerning symptoms, such as severe palpitations, which was observed among half the participants. Additional data on the climbers’ blood oxygen levels and physical condition were also collected.

The most commonly identified cardiac abnormality were significant pauses, which were recorded on 81 occasions and affected 50 percent of the subjects. Both the frequency and duration of the pauses increased the higher the climbers went, with the longest pause lasting seven seconds. One climber experienced an episode of a sustained symptomatic irregular fast heartbeat known as atrial fibrillation that lasted for nearly five hours and had kept him awake at night, and another developed a fast abnormal heart rhythm know as a supraventricular tachycardia (SVT) lasting 31 seconds while he attempted to lift a heavy load.

Chris Boos, M.D., visiting professor at Leeds Beckett University and consultant cardiologist at Poole Hospital, who led this study explained: “Our research has delivered a unique and fascinating insight into cardiac physiology at high altitude, showing what happens to the heart rate and rhythm while you sleep and exercise at very high altitude.

“For the majority of mountaineers, there should be no cause for concern, as the pauses during sleep may simply represent normal physiological adaptation to the significant challenges of the very high altitude environment. However, going above 4,000 meters could potentially exacerbate any pre-existing conditions which climbers may or may not already be aware of, and this should be taken into account when planning expeditions.”

He added: “Our study also shows the potential of this kind of technology for delivering medical diagnoses to people in extremely remote locations.”

The team plans to continue its investigations with larger groups of subjects and using even more recent advances in cardiac non-invasive monitoring technology, which will enable even greater detail to be recorded without the need for devices to be implanted.

For more information: www.circ.ahajournals.org


Related Content

Case Study | Implantable Cardiac Monitor (ICM)

Every second counts when someone is having a stroke and immediate care can mean the difference between life and death ...

Home July 02, 2025
Home
News | Implantable Cardiac Monitor (ICM)

July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...

Home July 11, 2024
Home
News | Implantable Cardiac Monitor (ICM)

October 3, 2023 -- Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation ...

Home October 03, 2023
Home
Feature | Implantable Cardiac Monitor (ICM)

The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...

Home June 13, 2023
Home
News | Implantable Cardiac Monitor (ICM)

May 18, 2023 — Abbott announced its Assert-IQ insertable cardiac monitor (ICM) has received U.S. Food and Drug ...

Home May 18, 2023
Home
News | Implantable Cardiac Monitor (ICM)

May 4, 2023 — Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., a company focused on improving long ...

Home May 04, 2023
Home
News | Implantable Cardiac Monitor (ICM)
April 29, 2022 – Medtronic has announced new data from the STROKE AF clinical trial, which showed that large and small ...
Home April 29, 2022
Home
News | Implantable Cardiac Monitor (ICM)
April 6, 2022 – Final results from the BIO|GUARD-MI study show a 31 percent reduction of MACE in a sub-group analysis of ...
Home April 06, 2022
Home
News | Implantable Cardiac Monitor (ICM)

September 7, 2021 — Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of ...

Home September 07, 2021
Home
News | Implantable Cardiac Monitor (ICM)

August 9, 2021 - In association with Heart Rhythm 2021, Biotronik today announced that the latest implantable cardiac ...

Home August 09, 2021
Home
Subscribe Now